ロード中...
Evaluation of the COVID19 ID NOW EUA assay
BACKGROUND: The SARS-CoV-2 pandemic caused a major surge in needed diagnostic capacity. In response, many EUA assays have become available for clinical laboratories, and more recently, the point of care device, Abbott ID NOW. OBJECTIVES: To determine the analytical performance of the ID NOW assay fo...
保存先:
| 出版年: | J Clin Virol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier B.V.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7227587/ https://ncbi.nlm.nih.gov/pubmed/32425657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2020.104429 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|